This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Mar;249(3):541-2; author reply 542.

doi: 10.1097/SLA.0b013e31819aa76e.

Intrahepatic cholangiocarcinoma

Gennaro Nuzzo, Felice Giuliante, Francesco Ardito, Ivo Giovannini

PMID: 19247046
DOI: 10.1097/SLA.0b013e31819aa76e

Comment

Intrahepatic cholangiocarcinoma

Gennaro Nuzzo et al. Ann Surg. 2009 Mar.

. 2009 Mar;249(3):541-2; author reply 542.

doi: 10.1097/SLA.0b013e31819aa76e.

Authors

Gennaro Nuzzo, Felice Giuliante, Francesco Ardito, Ivo Giovannini

PMID: 19247046
DOI: 10.1097/SLA.0b013e31819aa76e

No abstract available

PubMed Disclaimer

Comment on

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Endo I, et al. Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3. Ann Surg. 2008. PMID: 18580211

Similar articles

Clinical presentation and management of intrahepatic cholangiocarcinoma.
Farges O, Fuks D. Farges O, et al. Gastroenterol Clin Biol. 2010 Mar;34(3):191-9. doi: 10.1016/j.gcb.2010.01.006. Epub 2010 Mar 4. Gastroenterol Clin Biol. 2010. PMID: 20202770 Review. No abstract available.
Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma.
Yamamoto M, Ariizumi S. Yamamoto M, et al. J Gastroenterol. 2006 Sep;41(9):925-6. doi: 10.1007/s00535-006-1901-3. J Gastroenterol. 2006. PMID: 17048061 No abstract available.
[Surgical treatment for intrahepatic cholangiocarcinoma].
Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Nakagohri T, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:469-75. Nihon Rinsho. 2006. PMID: 16457307 Review. Japanese. No abstract available.
[To further improve the effects of surgical treatment for hilar cholangiocarcinoma].
Chen XP, Huang ZY. Chen XP, et al. Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1121-2. Zhonghua Wai Ke Za Zhi. 2009. PMID: 20021897 Chinese. No abstract available.
Peripheral cholangiocarcinoma and intrahepatic calculi.
Okuda K. Okuda K. J Gastroenterol Hepatol. 1999 Dec;14(12):1141-3. J Gastroenterol Hepatol. 1999. PMID: 10634148 No abstract available.

See all similar articles

Cited by

Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadjuvant therapy with the PD-1 inhibitor camrelizumab: A case report.
Zhu SG, Li HB, Dai TX, Li H, Wang GY. Zhu SG, et al. World J Clin Cases. 2022 Sep 26;10(27):9743-9749. doi: 10.12998/wjcc.v10.i27.9743. World J Clin Cases. 2022. PMID: 36186195 Free PMC article.
Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation.
Song F, Lu CL, Wang CG, Hu CW, Zhang Y, Wang TL, Han L, Chen Z. Song F, et al. Front Pharmacol. 2023 Mar 2;14:1129709. doi: 10.3389/fphar.2023.1129709. eCollection 2023. Front Pharmacol. 2023. PMID: 36937833 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information